Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities
This narrative review was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on title and PubMed metadata review. It appears low priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.
This narrative review was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on title and PubMed metadata review. It appears low priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.
What the study was
- Study design
- Narrative review
- Maturity
- Exploratory
- Journal
- Journal of translational medicine
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.